Radioiodination: Theory, Practice, and Biomedical Applications

Lingua: inglese

Editore: Springer US, Springer New York Jan 1992, 1992

0792314913 / 9780792314912

Serie: Libro 9 di 33 - Developments in Nuclear Medicine

Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000

Venditore con 5 stelle

Venditore AbeBooks dal 23 gennaio 2017

Rilegato

Condizione: Nuovo

EUR 320,99

EUR 60,00 spedizione 
Spedito da Germania a U.S.A.

Quantità: 1 disponibile

Aggiungi al carrello
Resi gratuiti per 30 giorni

Descrizione dell’articolo da parte del venditore

This item is printed on demand - Print on Demand Titel. Neuware -Among the readily available -emitting radionuclides, the nuclides of iodine have the greatest versatility in labeling both the hydrophilic and the lipophilic compounds that are used in biology and medicine. Biologically important micrmolecules, semimacromolecules, and macromolecules have been identified which, after iodination, almost maintain the same molecular configuration and similar biologic specificity as those of the parent molecules. The multiple techniques for iodination and the clinical use of iodinated products have made possible the present status of the development of diagnostic nuclear medicine. 125r, with a half-life of 60 days, has a crucial role in competitive protein-binding studies. 131r is useful for measuring thyroid uptake, for the diagnosis of thyroid carcinoma and metastasis, and for therapy. 1nr , with a reasonably shorter half-life, is almost ideal for thyroid workup and for a few useful labeled radiopharmaceutical. Although ~c is used more widely in diagnostic procedures, the radionuclides of iodine will always have a major role in biology and medicine. A considerable amount of information is scattered in the literature regarding the chemistry of radioiodination and the mechanism of tracer localization in cells and tissues. Labeled peptides, proteins, and antibodies are extensively used for protein turnover studies, receptor binding and tumor imaging studies, and radioimmunoassay. The general trend in the use of tracers in clinical nuclear medicine has been an evolution from 3H, 14C, 11C, and 13 to 125 , 131 and 123r to ~c and 111rn.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 660 pp. Englisch.…

Titolo
Radioiodination: Theory, Practice, and Biomedical Applications
Autore
Mrinal K. Dewanjee
Editore
Springer US, Springer New York Jan 1992
Anno di pubblicazione
1992
Condizione
Neu
Rilegatura
Buch
Lingua
inglese
ISBN 10
0792314913
ISBN 13
9780792314912
Peso dell'articolo
1144 grammi
Dimensioni
241x160x40 mm
Serie
Libro 9 di 33: Developments in Nuclear Medicine

buchversandmimpf2000

Emtmannsberg, BAYE, Germania

Venditore con 5 stelle

Venditore AbeBooks dal 23 gennaio 2017

Tariffe di spedizione da Germania a U.S.A.

ArticoloDa 60 a 60 giorni lavorativiDa 60 a 60 giorni lavorativi
Primo articoloEUR 60,00EUR 75,00
I tempi di consegna sono stabiliti dai venditori e variano in base al corriere e al paese. Gli ordini che devono attraversare una dogana possono subire ritardi e spetta agli acquirenti pagare eventuali tariffe o dazi associati. I venditori possono contattarti in merito ad addebiti aggiuntivi dovuti a eventuali maggiorazioni dei costi di spedizione dei tuoi articoli.

Metodi di pagamento

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay
  • Assegno
  • PayPal

Descrizione dello Store

Impressum Thorsten Retsch Buchversand Mimpf2000 Oberölschnitz 16 95517 Emtmannsberg Deutschland Telefon: 09209-2023188 Email: mimpf2000@online.de USt-ID-Nr.: DE 235096871 Wir führen gebrauchte Bücher aus allen Sparten der Literatur

Specializzazione

Modernes Antiquariat - Bücher von 1960 bis heute

Informazioni sull’azienda del venditore

buchversandmimpf2000

Germania

Impressum

Gesetzliche Anbieterkennung:

Thorsten Retsch
Buchversand Mimpf2000
Oberölschnitz 16
95517 Emtmannsberg
Deutschland
Telefon: 092092023188
E-Mail: order@buchversandmimpf2000.de
USt-IdNr.: DE 235096871

Alternative Streitbeilegung:
Die Europäische Kommission stellt eine Plattform für die außergerichtliche Online-Streitbeilegung (OS-Plattform) bereit, aufrufbar unter http://ec.europa.eu/odr.